Results 31 to 40 of about 41,202 (253)

Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil. [PDF]

open access: yes, 2019
Zika virus infection is associated with the development of Guillain-Barré syndrome (GBS), a neurological autoimmune disorder caused by immune recognition of gangliosides and other components at nerve membranes.
Alcantara, Luiz Carlos Junior   +7 more
core   +1 more source

A rare case of infectious mononucleosis complicated by Guillain-Barre syndrome

open access: yesNeurology International, 2013
Infectious mononucleosis is a clinical syndrome characterized by fever, lymphadenopathy and pharyngitis. Neurologic complications of infectious mononucleosis, such as the development of Guillain-Barre syndrome, have been rarely reported and usually ...
Margaret Kennedy, Mariya Apostolova
doaj   +1 more source

A Rare Cause of Walking Disorder in Childhood

open access: yesJournal of the Belgian Society of Radiology, 2022
Teaching point: Guillain-Barre Syndrome is a rare cause of a walking disorder during childhood. MRI is a key role for diagnosis.
Thomas Burguet, Pierre Reginster
doaj   +1 more source

Evaluation of post therapy functional status and residual weakness of patients with Guillain-Barre Syndrome [PDF]

open access: yes, 2020
: Introduction: The annual global incidence of Guillain-Barre Syndrome is approximately 1–2 per 100,000 person-years. Data on Guillain-Barre Syndrome is very rare from Pakistan, we conducted a retrospective study to assess the clinical presentation, and ...
Anis, Anam   +5 more
core   +1 more source

Guillain-Barré syndrome: a century of progress [PDF]

open access: yes, 2016
In 1916, Guillain, Barré and Strohl reported on two cases of acute flaccid paralysis with high cerebrospinal fluid protein levels and normal cell counts — novel findings that identified the disease we now know as Guillain–Barré syndrome (GBS).
A Campbell   +91 more
core   +1 more source

Electrophysiological evaluation of Guillain–Barre syndrome subtypes in childhood

open access: yesمجلة كلية الطب, 2017
Background: Guillain-Barre syndrome (GBS) is the most common cause of acute motor paralysis in children where most of electrophysiological findings reveal demyelinating neuropathy. However, an axonal form of Guillain-Barre syndrome had been reported too.
Lamees M. Hussein   +2 more
doaj   +1 more source

Experience of human normal immunoglobulin (Privigen, CSL BEHRING) administration in patients with Guillain - Barre syndrome in non-specialized neurological department

open access: yesСибирский научный медицинский журнал, 2019
Objective - to assess the own experience of human normal immunoglobulin (Privigen, CSL Behring) administration in patients with Guillain - Barre syndrome. Material and methods.
L. P. Smertina, V. Z. Movsumov
doaj   +1 more source

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals [PDF]

open access: yes, 2011
Objectives:  Anti-ganglioside antibodies are present in approximately half of Guillain–Barré syndrome (GBS) patients. Recently, it has been shown that a considerable proportion of these patients has serum antibodies against antigenic epitopes formed by a
Goodfellow   +22 more
core   +1 more source

Atypical Findings of Guillain-Barré Syndrome in Children [PDF]

open access: yes, 2013
How to cite this article: Karimzadeh P, Bakhshandeh Bali MK, Nasehi MM, Taheri Otaghsara SM, Ghofrani M. Atypical Findings of Guillain-Barré Syndrome in Children. Iran J Child Neurol Autumn 2012;6(4):17-22.
BAKHSHANDEH BALI, Mohammadkazem   +4 more
core   +3 more sources

Guillain Barre Syndrome – Effect of Plasma Pheresis: 6 months Study

open access: yesMRIMS Journal of Health Sciences, 2014
Guillain Barre Syndrome is an acute poly neuropathy, a disorder affecting the peripheral nervous system. The typical symptoms are ascending paralysis, weakness starting at the feet and hands, migrating towards the trunk.
B Bheeshma   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy